Home / Inspections / 1225068

FDA Inspection 1225068 — Teva Canada Limited

Teva Canada Limited — FEI 3002807750

The FDA completed an inspection of Teva Canada Limited on November 3, 2023 in Stouffville. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 3, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Stouffville (Canada)

Facility

Other inspections at this facility

  • 1097611 (VAI Fri May 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 996651 (VAI Fri Nov 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 865481 (NAI Fri Feb 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 771387 (NAI Fri Mar 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 566753 (VAI Fri Feb 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources